肝细胞癌在移植的供体肝脏中和结肠癌在一个复杂背景的患者中发展:一个病例报告
Sayoko Sumiyoshi1, Terumi Takahara2, Kazuto Shibuya3
1Department of Diagnostic Pathology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama 930-0194, Japan.
Oncology letters
|March 7, 2024
概括
肝细胞癌 (HCC) 发生在移植肝脏中,移植后19年. 这种罕见的病例凸显了与免疫抑制和微卫星不稳定性高 (MSI-H) 状态相关的潜在风险.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
- 移植手术 移植手术
背景情况:
- 肝移植是肝硬化患者的救生手术.
- 乙型肝炎病毒 (HBV) 阴性捐赠体通常用于乙型肝炎和肝硬化患者,以尽量减少风险.
- 移植肝脏中瘤的发展是不常见的.
相关概念视频
Bone Marrow Sampling and Transplants
3.1K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.1K
Tissue Transplantation
1.4K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K
Kidney Transplant I: Introduction
849
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
849


